V
Viome
Biotech & Life Sciences · Bellevue, United States · Founded 2016
Provides the industry’s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA) MoreLess
Viome operates in the health and wellness market, focusing on personalized nutrition and gut health solutions. The company serves individuals seeking to optimize their health through tailored dietary and supplement recommendations. Viome's core business model revolves around offering health tests that analyze the microbiome and cellular health, providing personalized insights and nutrition plans based on the results. The company leverages advanced mRNA technology and artificial intelligence to deliver precise health recommendations. Revenue is generated through the sale of health tests, personalized supplements, and probiotics subscriptions. Viome's target market includes health-conscious consumers looking for data-driven, personalized health solutions.
Keywords: microbiome, personalized nutrition, gut health, mRNA technology, AI platform, health tests, probiotics, supplements, cellular health, wellness.
Talent graph
Viome's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Viome has talent and traffic
team presence
across markets
Market sentiment
What the market is saying about Viome
An AI-synthesized read of the highest-engagement posts about Viome on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Viome on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.